| Bioactivity | CTTHWGFTLC, CYCLIC TFA is a cyclic peptide inhibitor for matrix metalloproteinases MMP-2 and MMP-9. The IC50 value for MMP-9 is ~8 μM[1]. | ||||||
| Invitro | CTTHWGFTLC, CYCLIC TFA inhibits endothelial and tumor cell migration in vitro[1]. | ||||||
| Name | CTTHWGFTLC, CYCLIC TFA | ||||||
| Sequence | Cys-Thr-Thr-His-Trp-Gly-Phe-Thr-Leu-Cys (Disulfide Bridge: Cys1-Cys10) | ||||||
| Shortening | CTTHWGFTLC (Disulfide Bridge: Cys1-Cys10) | ||||||
| Formula | C54H72F3N13O16S2 | ||||||
| Molar Mass | 1280.35 | ||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||
| Storage | Sealed storage, away from moisture and light, under nitrogen
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light, under nitrogen) |
CTTHWGFTLC, CYCLIC TFA
CAS: F: C54H72F3N13O16S2 W: 1280.35
CTTHWGFTLC, CYCLIC TFA is a cyclic peptide inhibitor for matrix metalloproteinases MMP-2 and MMP-9. The IC50 value for M
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.